Residual DOAC levels according to interruption interval. The proportion of patients with residual preprocedural levels ≥30 ng/mL and ≥50 ng/mL declines with increasing interruption duration. (A) Apixaban. (B) Dabigatran. (C) Rivaroxaban.  Apixaban was associated with a higher likelihood of levels ≥30 ng/mL compared with dabigatran and of levels ≥50 ng/mL when compared with rivaroxaban for low-risk procedures with shorter interruption intervals. Rivaroxaban was associated with a higher likelihood of levels ≥30 ng/mL as compared with apixaban for high-risk procedures with longer interruption intervals.